LBRX Strangle Strategy
LBRX (LB Pharmaceuticals Inc Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
LBRX (LB Pharmaceuticals Inc Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $915.4M, a beta of 0.71 versus the broader market, a 52-week range of 13.36-33.47, average daily share volume of 257K, a public-listing history dating back to 2025, approximately 16 full-time employees. These structural characteristics shape how LBRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.71 places LBRX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on LBRX?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current LBRX snapshot
As of June 30, 2026, spot at $33.00, ATM IV 119.30%, expected move 34.20%. The strangle on LBRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this strangle structure on LBRX specifically: IV rank is unavailable in the current snapshot, so regime-based timing for LBRX is inferred from ATM IV at 119.30% alone, with a market-implied 1-standard-deviation move of approximately 34.20% (roughly $11.29 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LBRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on LBRX should anchor to the underlying notional of $33.00 per share and to the trader's directional view on LBRX stock.
LBRX strangle setup
The LBRX strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LBRX near $33.00, the first option leg uses a $34.65 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LBRX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LBRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $34.65 | N/A |
| Buy 1 | Put | $31.35 | N/A |
LBRX strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
LBRX strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on LBRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on LBRX
Strangles on LBRX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LBRX chain.
LBRX thesis for this strangle
The market-implied 1-standard-deviation range for LBRX extends from approximately $21.71 on the downside to $44.29 on the upside. A LBRX long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. As a Healthcare name, LBRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LBRX-specific events.
LBRX strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LBRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LBRX alongside the broader basket even when LBRX-specific fundamentals are unchanged. Always rebuild the position from current LBRX chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on LBRX?
- A strangle on LBRX is the strangle strategy applied to LBRX (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With LBRX stock trading near $33.00, the strikes shown on this page are snapped to the nearest listed LBRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LBRX strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the LBRX strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 119.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LBRX strangle?
- The breakeven for the LBRX strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LBRX market-implied 1-standard-deviation expected move is approximately 34.20%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on LBRX?
- Strangles on LBRX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LBRX chain.
- How does current LBRX implied volatility affect this strangle?
- Current LBRX ATM IV is 119.30%; IV rank context is unavailable in the current snapshot.